1. Home
  2. PRPH vs PIII Comparison

PRPH vs PIII Comparison

Compare PRPH & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPH
  • PIII
  • Stock Information
  • Founded
  • PRPH 1989
  • PIII 2015
  • Country
  • PRPH United States
  • PIII United States
  • Employees
  • PRPH N/A
  • PIII N/A
  • Industry
  • PRPH Biotechnology: Pharmaceutical Preparations
  • PIII Medical/Nursing Services
  • Sector
  • PRPH Health Care
  • PIII Health Care
  • Exchange
  • PRPH Nasdaq
  • PIII Nasdaq
  • Market Cap
  • PRPH 17.7M
  • PIII 20.8M
  • IPO Year
  • PRPH 1997
  • PIII N/A
  • Fundamental
  • Price
  • PRPH $0.28
  • PIII $6.60
  • Analyst Decision
  • PRPH
  • PIII Buy
  • Analyst Count
  • PRPH 0
  • PIII 2
  • Target Price
  • PRPH N/A
  • PIII $16.25
  • AVG Volume (30 Days)
  • PRPH 1.1M
  • PIII 12.6K
  • Earning Date
  • PRPH 08-13-2025
  • PIII 08-14-2025
  • Dividend Yield
  • PRPH N/A
  • PIII N/A
  • EPS Growth
  • PRPH N/A
  • PIII N/A
  • EPS
  • PRPH N/A
  • PIII N/A
  • Revenue
  • PRPH $5,845,000.00
  • PIII $1,485,192,000.00
  • Revenue This Year
  • PRPH $221.82
  • PIII N/A
  • Revenue Next Year
  • PRPH N/A
  • PIII $7.92
  • P/E Ratio
  • PRPH N/A
  • PIII N/A
  • Revenue Growth
  • PRPH N/A
  • PIII 9.79
  • 52 Week Low
  • PRPH $0.22
  • PIII $5.80
  • 52 Week High
  • PRPH $3.00
  • PIII $31.50
  • Technical
  • Relative Strength Index (RSI)
  • PRPH 35.31
  • PIII 46.26
  • Support Level
  • PRPH $0.30
  • PIII $6.37
  • Resistance Level
  • PRPH $0.35
  • PIII $7.95
  • Average True Range (ATR)
  • PRPH 0.04
  • PIII 0.53
  • MACD
  • PRPH -0.01
  • PIII -0.05
  • Stochastic Oscillator
  • PRPH 1.93
  • PIII 37.21

About PRPH ProPhase Labs Inc. (DE)

ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.

About PIII P3 Health Partners Inc.

P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.

Share on Social Networks: